Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Melanoma 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

pembrolizumab 3Ipilimumab 3Educational Status 3Biopsy 3Optical Imaging 2Nivolumab 2Early Intervention, Educational 2Ascorbic Acid 2methyl 5-aminolevulinate 1lavender oil 1four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate) 1fludarabine phosphate 1fludarabine 1aldesleukin 1Zinc 1Water 1Trimethoprim, Sulfamethoxazole Drug Combination 1Tomography, Optical Coherence 1Toll-Like Receptor 1 1Tea 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Semaxinib 1Second Harmonic Generation Microscopy 1Risk Factors 1Resistance Training 1Radiotherapy, Image-Guided 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Skin Neoplasms × lavender oil × Clear all
NCT06167096 2026-03-05

Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery

Case Comprehensive Cancer Center

Phase NA Completed
89 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡